2007
DOI: 10.1111/j.1365-2230.2007.02426.x
|View full text |Cite
|
Sign up to set email alerts
|

A case of cutaneous extravascular necrotizing granuloma without systemic manifestations

Abstract: Cutaneous extravascular necrotizing granuloma, an unusual palisading dermal granuloma, was first described by Churg and Strauss in 1951 in association with the syndrome of allergic granulomatosis (Churg-Strauss syndrome), for which it was though to be pathognomonic. It has subsequently been described in association with a number of autoimmune and immunoreactive diseases, and is regarded as a cutaneous marker of systemic pathology. To our knowledge, only one patient has been reported with clinical features conf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0
3

Year Published

2010
2010
2022
2022

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 8 publications
0
7
0
3
Order By: Relevance
“…Certain drugs have also been reported to trigger a microscopically identical eruption, and there are several recent reports of PNGD occurring in patients receiving tumour necrosis factor‐α inhibitor therapy 4 . Rarely, there is no detectable associated condition 5 . In our patient, a full autoantibody screen and rheumatoid factor were negative.…”
Section: Discussionmentioning
confidence: 47%
See 1 more Smart Citation
“…Certain drugs have also been reported to trigger a microscopically identical eruption, and there are several recent reports of PNGD occurring in patients receiving tumour necrosis factor‐α inhibitor therapy 4 . Rarely, there is no detectable associated condition 5 . In our patient, a full autoantibody screen and rheumatoid factor were negative.…”
Section: Discussionmentioning
confidence: 47%
“…4 Rarely, there is no detectable associated condition. 5 In our patient, a full autoantibody screen and rheumatoid factor were negative. Full screening for associated disorders in our patient was unremarkable.…”
Section: Discussionmentioning
confidence: 57%
“…В подавляющем большинстве случаев это васкулиты, индуцированные лекарственными препаратами (лекарственно-индуцированный ANCA-ассоциированный васкулит), при которых чаще выявляются антитела MPO-ANCA, чем PR3-ANCA. Критерием диагностики является наличие связи между приемом медикаментов и началом развития изменений в коже, а также быстрое разрешение высыпаний после прекращения поступления лекарственного препарата в организм [11][12][13]. Все васкулиты, обусловленные отложением иммунных комплексов, за исключением анти-GBM болезни (Glomerular Basement Membrane IgG antibody -болезнь с образованием антител к базальной мембране клубочков), могут поражать сосуды кожи.…”
Section: классификацияunclassified
“…Vestnik Dermatologii i Venerologii. 2020; 96 (1): [10][11][12][13][14][15][16][17] Вестник дерматологии и венерологии. 2020; 96 (1): 10-17 № 1, 2020 В настоящее время нет общепринятой терминологии и классификации васкулитов и сосудистых нарушений кожи.…”
unclassified
“…Most of them are drug‐induced cutaneous AAVs (see more details below). However, there are single case reports of AAV limited to the skin with no linkage to disease‐eliciting drugs or other causal factors (Table ).…”
Section: Introductionmentioning
confidence: 99%